Oncology-new York

Oncology-new York英文簡介

Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.

Oncology-new York中文簡介

《Oncology-new York》是一本由UBM Medica Healthcare Publications出版商出版的專業(yè)醫(yī)學期刊，該刊創(chuàng)刊于1987年，刊期Monthly，該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學科：醫(yī)學 3區(qū)，小類學科：腫瘤學 4區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q4。該刊發(fā)文范圍涵蓋腫瘤學等領域，旨在及時、準確、全面地報道國內(nèi)外腫瘤學工作者在該領域取得的最新研究成果、工作進展及學術(shù)動態(tài)、技術(shù)革新等，促進學術(shù)交流，鼓勵學術(shù)創(chuàng)新。2021年影響因子為2.533，平均審稿速度較慢,6-12周。

中科院分區(qū)最新升級版（當前數(shù)據(jù)版本：2021年12月最新升級版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	4區(qū)	ONCOLOGY 腫瘤學	4區(qū)	否	否

JCR分區(qū)（當前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學科	分區(qū)	影響因子
Q4	ONCOLOGY	Q4	2.533

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
2.533	67	1.32%	0.00%	未開放	較慢,6-12周

IF值(影響因子)趨勢圖